Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05544344 · ClinicalTrials.gov registry record · NA
Healthy ReStart Intervention to Improve Health and Functioning
A NA study of Mental Disorder, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05544344: Recruiting NA study of Mental Disorder, sponsored by University of Illinois at Chicago.
NCT05544344 is a NA study of Mental Disorder that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 60 participants, below the 322-participant average among 21 other Mental Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05544344, a NA study of Mental Disorder, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests an intervention that uses health coaching, motivational interviewing, positive psychology, and online wellness tools to help adults with mental illness return to active lives after major disruptions such as the COVID-19 pandemic.
Primary Outcome
Change in participants' feelings of competence about their ability to improve their lives and follow through on their life goals as measured by the Perceived Competence scale. This 4-item scale using a 7-point Likert response format ranging from "not at all true" to "very true." The minimum value is 4 and the maximum is 28, with higher scores indicating a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Healthy ReStart
- OTHER Services as Usual
Study Locations (1)
Illinois
- Trilogy Behavioral Health Care - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05544344 shows while recruiting
NCT05544344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 322-participant average among 21 other Mental Disorder trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Mental Disorder appearing as the primary indexed condition, and to 2 interventions - of which Healthy ReStart is the first listed.
NCT05544344 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05544344 about?
NCT05544344 is a clinical study titled "Healthy ReStart Intervention to Improve Health and Functioning". This study tests an intervention that uses health coaching, motivational interviewing, positive psychology, and online wellness tools to help adults with mental illness return to active lives after major disruptions such as the COVID-19 pandemic.
What is the current status of trial NCT05544344?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-07-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05544344 study?
This clinical trial studies the following conditions: Mental Disorder.
What interventions are being tested in trial NCT05544344?
The interventions under investigation include: Healthy ReStart (BEHAVIORAL), Services as Usual (OTHER).
Who is sponsoring clinical trial NCT05544344?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05544344 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05544344's enrollment target sits among peer trials
60 16th of 21 higher than 5 of 21 other Mental Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mental Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT for HIV-Positive Men
RECRUITING · NA
-
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
RECRUITING · NA
-
Enhancing Immune Health Randomized Controlled Trial
RECRUITING · NA
-
Transdiagnostic Behavior Therapy Vs TAU for Adjustment Disorder Following Traumatic Event Exposure
RECRUITING · NA
-
Brain Stimulation to the Hippocampus in Schizophrenia
RECRUITING · NA
-
FCT Study: Reducing the Need for Out-of-Home Placements
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI